JP2001514886A5 - - Google Patents

Download PDF

Info

Publication number
JP2001514886A5
JP2001514886A5 JP2000509826A JP2000509826A JP2001514886A5 JP 2001514886 A5 JP2001514886 A5 JP 2001514886A5 JP 2000509826 A JP2000509826 A JP 2000509826A JP 2000509826 A JP2000509826 A JP 2000509826A JP 2001514886 A5 JP2001514886 A5 JP 2001514886A5
Authority
JP
Japan
Prior art keywords
ccr2
antibody
pharmaceutical composition
nucleic acid
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000509826A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001514886A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/016523 external-priority patent/WO1999009162A2/en
Publication of JP2001514886A publication Critical patent/JP2001514886A/ja
Publication of JP2001514886A5 publication Critical patent/JP2001514886A5/ja
Pending legal-status Critical Current

Links

JP2000509826A 1997-08-14 1998-08-10 Ccr2遺伝子のミスセンス対立遺伝子によるaidsへの進行の遅延 Pending JP2001514886A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5565997P 1997-08-14 1997-08-14
US60/055,659 1997-08-14
PCT/US1998/016523 WO1999009162A2 (en) 1997-08-14 1998-08-10 Delayed progression to aids by a missense allele of the ccr2 gene

Publications (2)

Publication Number Publication Date
JP2001514886A JP2001514886A (ja) 2001-09-18
JP2001514886A5 true JP2001514886A5 (https=) 2006-01-05

Family

ID=21999344

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000509826A Pending JP2001514886A (ja) 1997-08-14 1998-08-10 Ccr2遺伝子のミスセンス対立遺伝子によるaidsへの進行の遅延

Country Status (8)

Country Link
US (1) US6600030B2 (https=)
EP (1) EP1002081B1 (https=)
JP (1) JP2001514886A (https=)
AT (1) ATE329022T1 (https=)
AU (1) AU754640B2 (https=)
CA (1) CA2300093A1 (https=)
DE (1) DE69834814D1 (https=)
WO (1) WO1999009162A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995019436A1 (en) * 1994-01-13 1995-07-20 The Regents Of The University Of California Mammalian monocyte chemoattractant protein receptors
CA2312288A1 (en) * 1998-03-27 1999-10-07 Johnson & Johnson Research Pty. Limited Catalytic nucleic acid-based diagnostic methods
WO2001027330A2 (en) * 1999-10-12 2001-04-19 Board Of Regents, The University Of Texas System Screening for disease susceptibility by genotyping the ccr5 and ccr2 genes
US7393634B1 (en) 1999-10-12 2008-07-01 United States Of America As Represented By The Secretary Of The Air Force Screening for disease susceptibility by genotyping the CCR5 and CCR2 genes
GB0004183D0 (en) * 2000-02-22 2000-04-12 Smithkline Beecham Plc New use
RU2180922C1 (ru) * 2001-03-14 2002-03-27 Ромащенко Аида Герасимовна Способ определения аллелей гена хемокинового рецептора ccr2 по полиморфному сайту v64i
US20030099621A1 (en) * 2001-11-29 2003-05-29 Robert Chow Stem cell screening and transplantation therapy for HIV infection
US20050106731A1 (en) * 2002-08-05 2005-05-19 Davidson Beverly L. siRNA-mediated gene silencing with viral vectors
WO2005101002A1 (en) * 2004-04-13 2005-10-27 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 2 (ccr2)
US11045929B1 (en) 2016-04-26 2021-06-29 Bright Machines, Inc. Angle screw feeding module
US12319958B2 (en) * 2020-07-21 2025-06-03 Rutgers, The State University Of New Jersey Method and kit for CCR2 expression profiling and disease stratification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995019436A1 (en) * 1994-01-13 1995-07-20 The Regents Of The University Of California Mammalian monocyte chemoattractant protein receptors
SE9600820D0 (sv) 1996-03-01 1996-03-01 Pharmacia Ab Antibodies and their use
AU5812498A (en) * 1996-12-20 1998-07-17 Merck & Co., Inc. Substituted aminoquinolines as modulators of chemokine receptor activity

Similar Documents

Publication Publication Date Title
Wakita et al. Detection of pre-C and core region mutants of hepatitis B virus in chronic hepatitis B virus carriers.
JP2001514886A5 (https=)
JP2015514709A (ja) 新規のインターフェロン−λ4(IFNL4)タンパク質、関連の核酸分子、並びにそれらの使用
JP2002521065A5 (https=)
JP2005058234A (ja) B型肝炎検査用のpcrプライマーセット及びそれを利用したb型肝炎検査方法
Wright et al. Conserved sequence homology of cysteine-rich regions in genes encoding glycoprotein A in Pneumocystis carinii derived from different host species
JP2005518203A (ja) M.tuberculosisの欠失配列、これらの配列を用いるマイコバクテリアの検出方法、およびワクチン
CN109913482B (zh) Pik3ca-i874r突变基因及其在乳腺癌辅助诊断中的应用
CN111304332B (zh) 一种乳腺癌相关基因BRCA2位点g.32336265G>T突变体的检测
Cantrell et al. Isolation of markers from recently transposed LINE-1 retrotransposons
CA2637307A1 (en) Quantitative hiv phenotype or tropism assay
JP2009511026A (ja) 血栓塞栓性及び冠状動脈性心疾患の診断方法
US6800463B1 (en) Method for mutation detection in HIV-1 using pol sequencing
JP2554612B2 (ja) 相補肝炎aウイルスゲノムを含有している雑種dnaの調製法、該雑種dna、これを含有するプラスミドベクタ−、雑種dnaによって発現されたウイルス特異蛋白質およびこれから調製され、これらを含有するワクチン
CN100412190C (zh) 乙肝病毒全基因组多聚酶嵌合体的组建方法和应用
CN111304211B (zh) Rhd-t268a突变体及其检测
CN109913481B (zh) PIK3CA基因g.179224821G>A突变及其在乳腺癌辅助诊断中的应用
CN101525620B (zh) Coppock白内障致病基因及其检测方法
CN112941205A (zh) 一种RhD血型基因RHD634G>A等位基因及检测
JP4111481B2 (ja) 心筋梗塞の遺伝的要因を判定するための方法及びこれに使用されるオリゴヌクレオチド
CN112940099B (zh) RhD-T163P突变体及其检测
CN101532048A (zh) 乙型肝炎病毒核心启动子区突变及其用途
EP1696040A1 (en) Method of genotyping and phenotyping hepatitis B viruses resistant to antiviral molecules
Ma et al. Sequence variability of the human cytomegalovirus UL141 Open Reading Frame in clinical strains
JP2001238687A (ja) C型肝炎ウイルスの遺伝子型の判定方法